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ABSTRACT
The histone methyltransferase Dot1 is conserved
from yeast to human and methylates lysine 79 of hi-
stone H3 (H3K79) on the core of the nucleosome.
H3K79 methylation by Dot1 affects gene expression
and the response to DNA damage, and is enhanced
by monoubiquitination of the C-terminus of histone
H2B (H2Bub1). To gain more insight into the func-
tions of Dot1, we generated genetic interaction maps
of increased-dosage alleles of DOT1. We identified
a functional relationship between increased Dot1
dosage and loss of the DUB module of the SAGA
co-activator complex, which deubiquitinates H2Bub1
and thereby negatively regulates H3K79 methyla-
tion. Increased Dot1 dosage was found to promote
H2Bub1 in a dose-dependent manner and this was
exacerbated by the loss of SAGA-DUB activity, which
also caused a negative genetic interaction. The stim-
ulatory effect on H2B ubiquitination was mediated
by the N-terminus of Dot1, independent of methyl-
transferase activity. Our findings show that Dot1 and
H2Bub1 are subject to bi-directional crosstalk and
that Dot1 possesses chromatin regulatory functions
that are independent of its methyltransferase activity.
INTRODUCTION
During gene transcription, several histone modifica-
tions are deposited along transcribed regions. These
post-translational modifications influence subsequent
genome transactions such as transcription elongation,
co-transcriptional RNA modification and processing, and
the response to DNA damage and DNA repair (1–5).
The introduction of co-transcriptional modifications can
be mediated by interactions of the responsible modifying
enzymes with RNA polymerase or with transcription
elongation factors such as DRB Sensitivity Inducing
Factor (DSIF) or the Paf1 complex (Paf1C; polymerase II
associated factor) (6). From budding yeast to mammals,
the Paf1C complex mediates the recruitment of enzymes
responsible for monoubiquitination of the C-terminus of
histone H2B (H2Bub1) (6–9). This bulky modification
has been proposed to change the stability of nucleosomes
as well as influence the structure of chromatin (10,11).
H2Bub1 is a covalent modification but highly dynamic.
The attachment of ub1 by the ubiquitin ligase Bre1, in con-
junction with Lge1 and the ubiquitin-conjugating enzyme
Rad6 in yeast, is counteracted by deubiquitinating enzymes
(DUBs) Ubp8 and Ubp10, which act at distinct locations
in the genome (12,13). Ubp8 is part of the deubiquitination
(DUB) module of the Spt-Ada-Gcn5 acetyltransferase
(SAGA) co-activator complex, which acts at promoter re-
gions (14). Ubp10 is recruited by Sir4 to domains of silent
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chromatin, where it helps in maintaining a repressive chro-
matin state, but it also acts at euchromatic genes (12,15–17).
In addition to having direct effects on chromatin structure
and function, H2Bub1 is an important node for signaling
to other histone modifications (11,18,19). In particular,
in yeast, H2Bub1 promotes methylation of H3K4 by the
Set1/COMPASS complex, methylation of H3K36 by Set2
and methylation of H3K79 by Dot1 (e.g. see (20)), and
similar effects have been observed in metazoans (11,21,22).
Dot1 and methylation of H3K79 are involved in gene
expression and silencing, the DNA damage response and
DNA repair, and checkpoint activation in meiosis (8,23).
In addition, misregulation of DOT1L in mouse and hu-
man can lead to the development of cancer (24–26). Cur-
rent evidence from studies in yeast and with DOT1L in vitro
suggest that H2Bub1 promotes the activity of Dot1 not by
increased recruitment, but instead by physically corralling
the enzyme into a productive binding orientation, promot-
ing all methylation steps from unmethylated H3K79 to
H3K79me1, -me2 and -me3 (19,27). As a consequence, co-
transcriptional H2Bub1 deposition leads to a high methy-
lation state (H3K79me3) in transcribed regions, whereas
in intergenic regions or silent chromatin, where H2Bub1 is
low, only lower methylation states (H3K79me1 and -me2)
are deposited (20,28,29). Recently, several additional mech-
anisms of regulation of Dot1 have been described, some of
which also impinge on theH2Bub-H3K79me crosstalk (20).
In addition to H3K79 methylation, Dot1 has recently
been shown to possess histone chaperone activity, indepen-
dent of its histone methyltransferase activity (29). How-
ever, howDot1 andH3K79methylation influence the struc-
ture and function of chromatin at a molecular level is still
poorly understood. In order to obtain more insight into
the functions of Dot1, we performed genetic interaction
screens using gain-of-function alleles of DOT1. This ap-
proach uncovered that increased Dot1 dosage leads to in-
creasedH2Bub1 levels, and that this effect is independent of
H3K79 methylation. Our findings support a revised model
of crosstalk between H2Bub1 and Dot1: H2Bub1 promotes
H3K79me synthesis, while the Dot1 N-terminal domain in-
creases H2Bub1 levels, providing a potential positive feed-
back mechanism.
MATERIALS AND METHODS
Yeast strains, plasmids and growth conditions
Strains and plasmids used for the indicated figures are de-
scribed in Supplementary Tables S1 and S2, respectively.
Media were described previously (30). Strain NKI2378 was
derived from Y7092 by first replacing the DOT1 coding
sequence by a URA3 cassette from pR306 (31), then re-
placing the URA3 cassette by the DOT1-G401R coding
sequence derived from pFvL053 (32) and finally integrat-
ing the TDH3 promoter amplified from pYM-N15 (33)
in front of the DOT1 gene. NKI6142 was derived from
NKI6061 by replacing the BRE1 coding sequence with the
HphMX cassette from pFvL100 (34). NKI6152 was de-
rived from NKI6061 by first replacing the DOT1 coding
sequence by a URA3 cassette from pR306 (31), then re-
placing the URA3 cassette by the DOT1-G401A coding se-
quence derived from pFvL054 (32) and finally integrating
the TDH3 promoter amplified from pYM-N15 (33) in front
of the DOT1 gene. NKI6153 was derived from NKI6061
by first replacing the DOT1 coding sequence by a URA3
cassette from pRS306 (31), then replacing the URA3 cas-
sette by theDot12-172 fragment (amplified from pFF001,
a derivative of pRS315-STR1 (34)) and finally integrating
the TDH3 promoter amplified from pYM-N15 (33) in front
of the DOT1 gene. NKI8048 and NKI8049 were derived
from BY4742 by first replacing the DOT1 coding sequence
by a URA3 cassette from pRS306 (31) and then replacing
the URA3 cassette by the DOT1-G401V coding sequence
derived from the pRS315-DOT1-G401V plasmid described
previously (35). NKI8046-49 were generated by integrat-
ing the KanMX-TDH3 and KanMX-TEF1 promoter cas-
sette amplified from pYM-N14 and pYM-N18, respec-
tively (33) in front of the DOT1 gene. NKI2509, NKI2544,
NKI2512, NKI2515, NKI2518 and NKI2521 were gen-
erated by replacing the DOT1 coding sequence with the
NatMX cassette from pFvL99 (34). NKI2510, NKI2545,
NKI2513, NKI2516, NKI2519, NKI2522, NKI2528 and
NKI2566 were generated by integrating theNatNT2-TDH3
promoter cassette amplified from pYM-N15 (33) in front
of the DOT1 gene. pFvL006 was derived from pFvL018
to generate pTCG-DOT1-254-582. pFvL019 was derived
from pFvL018 by deletion of a 1.3 kb NruI–BamHI frag-
ment to generate pTCG-DOT1-1-172. Strains NKI3027
and NKI3028 were derived from UCC7315 by replac-
ing plasmid pCS1 with pRG422 and pRG423, respectively
(36). Strains NKI2563 and NKI2564 were derived from
UCC6288 by replacing plasmid pCS1 with pRG422 and
pRG423, respectively (36). Strain UCC6288 was derived
from UCC7315 by replacing the UBP8 coding sequence
by a KanMX cassette from pRS400 (31). Strain NKI2527
was derived from Y7092 by replacing the PAF1 coding se-
quence by a KanMX cassette from pRS400 (31). NKI4748
was isolated from the Epi-Decoder library described else-
where (37).
Genetic interaction analysis
High-throughput genetic interactions were determined
based on epistatic miniarray profiling (E-MAP) (38). Dou-
ble mutants were constructed using the RoToR from Singer
Instruments (Watchet, UK) and the synthetic genetic ar-
ray (SGA) technology (20,35,39). Static growth scores were
computed as previously described in (40). The library of
∼1400 deletion- and decreased abundance by mRNA per-
turbation (DAmP)-mutants has been described previously
(40).
Transcriptome analysis
Messenger RNA expression profiles of wild-type (WT)
(BY4742), dot1Δ (NKI3002), Dot1-OE (NKI8046 and
NKI8047) and Dot1-OE-G401V (NKI8048 and NKI8049,
overexpressing catalytically inactive Dot1 in the absence of
endogenous WT DOT1) were generated as part of a large
and uniform collection of deletion and perturbation mu-
tants (41,42). Expression profiling and data analysis were
performed as described previously (41,42).
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Protein detection by immunoblot and antibodies
For immunoblotting, strains were grown to mid-log phase
(OD660 0.6–0.9). Samples of 2 × 108 cells were harvested
and washed with Tris-EDTA (TE; 10 mM Tris pH 8, 1
mM ethylenediaminetetraacetic acid (EDTA)) containing
0.2 mM phenylmethane sulfonyl fluoride (PMSF). Cell pel-
lets were stored at −80◦C until further processing, but at
least 30 min. Whole-cell extracts were prepared in SUMEB
(1% sodium dodecyl sulfate (SDS); 8 M urea; 10 mM 3-(N-
morpholino)propanesulfonic acid, pH 6.8; 10 mM EDTA;
0.01% bromophenol blue) containing protease inhibitors (1
mM PMSF, 1 mM dithiothreitol, 5 mM benzamidine, 1
g/ml pepstatin, 1 g/ml leupeptin) by bead beating. The
resulting lysate was incubated for 10 min at 65◦C and sub-
sequently clarified by centrifuging 5 min at 21 × g. Before
immunoblotting, 4–10l of lysate (∼2× 106 cells) was sepa-
rated on a polyacrylamide gel (16% for histoneH3 andH2B,
10% for Pgk1, Dot1, FLAG and TAP). Separated proteins
were transferred to a 0.45-m nitrocellulose membrane for
1 (H3 and H2B) or 2 h (Pgk1, Dot1, FLAG, TAP) at 1 A.
Membranes were blocked with phosphate-buffered saline
(PBS) containing 2% or 5%Nutrilon (Nutricia) for 1 h, and
first antibody incubations (dilutions see below) were per-
formed overnight at 4◦C in 4 ml Tris-buffered saline con-
taining 0.05% Tween-20 (TBST) with 2% Nutrilon. After
washing three times in TBST, secondary antibody incuba-
tionwas performed inTBSTwith 2%Nutrilon andLI-COR
Odyssey IRDye 800CW antibody at 1:10 000 for 45 min at
room temperature in the dark followed by 10 min washes
twice in TBST and once in PBS. Membranes were scanned
using an LI-COROdyssey IR Imager (Biosciences) and an-
alyzed using Image Studio 2.0 (LI-COR). For density scans,
the signal was the sum of the individual pixel intensity val-
ues for a shape minus the product of the median intensity
values of the pixels in the background (with a border width
top/bottom of 3) and the total number of pixels enclosed by
the shape (Area): Signal = Sum − (Background × Area).
Primary antibodies and their dilutions used in this study
are Pgk1 (459250, Invitrogen, RRID:AB 221541; 1:4000),
Histone H2B (39238, Active Motif, RRID:AB 2631110;
1:2000), Flag (M2 F3165, Sigma, RRID:AB 259529;
1:4000), histoneH3 (RRID:AB 2631108 (43); 1:2000), TAP
(CAB1001, ThermoFisher Scientific, RRID:AB 10709700;
1:1000), Dot1-C (RRID:AB 2631109 (36); 1:2000), yDot1
(#144682, this manuscript, RRID:AB 2737408; 1:1000),
yH2BK123ub1 (this manuscript, 152107, Ximbio, RRID:
AB 2737407; 1:5000 (10 mg/ml)), H3K79me1 (RRID:
AB 2631105 (36); 1:1000), H3K79me2 (04–835, Milli-
pore, RRID:AB 1587126; 1:2000) and H3K79me3 (RRID:
AB 2631107 (36); 1:1000). Secondary antibodies used
are IRDye 800CW goat anti-Mouse igg (0.5 mg) 926-
32210 Li-COR (RRID:AB 621842) and IRDye 800CW
goat anti-Rabbit igg (0.5 mg) 926-32211 Li-COR (RRID:
AB 621843).
Chromatin immunoprecipitation (ChIP)
For chromatin immunoprecipitation (ChIP), cells were
grown to mid-log phase in Yeast Extract Peptone Dextrose
media (YEPD). Samples of 1−3 × 109 cells were taken,
fixed for 10 min in 1% formaldehyde, and washed with cold
TBS. Pellets were stored in 2-ml screw-cap tubes at −80◦C
until further processing. Cells in 2 ml screw-cap tubes were
disrupted in 400 l of breaking buffer (100 mM Tris, pH
7.9; 20% glycerol; protease inhibitor cocktail EDTA-free;
Roche) with 400 l of zirconia/silica beads with a Bead
beater (Biospec Products) for 2× 2 min in a cold aluminum
rack at 4◦C. Lysis was at least 70%, as determined by mi-
croscopy. Lysates were diluted with 1 ml of FA buffer (50
mM 4-(2-hydroxyethyl)-1-piperazine-ethanesulfonic acid–
KOH (HEPES–KOH), pH 7.5; 140 mM NaCl), 1 mM
EDTA; 1% Triton X-100; 0.1% Na-deoxycholate; protease
inhibitor cocktail EDTA-free. The mixture was centrifuged
for 1 min at 21 × g at 4◦C, and the pellet was washed
once more with FA buffer. The pellet was resuspended in
450 l of FA, divided over two 1.5 ml Bioruptor Micro-
tubes with Caps (Diagenode #C30010016) and sonicated
for 6−7 min in a Bioruptor Pico (Diagenode) with 30 s on–
off cycles on high power. Lysates were cleared by centrifu-
gation for 5 min at 4◦C at 21 000 × g. Supernatant con-
taining chromatin was transferred to a 1.5-ml tube and 1
ml of FA was added to samples. The chromatin solution
was centrifuged for 15 min at 21 000 × g at 4◦C; the super-
natant was transferred to a new 1.5-ml tube and stored at
−20◦C. Magnetic Dynabeads coupled with Protein G (Life
Technologies) were incubated in PBS containing 5 mg/ml
bovine serum albumin with antibody for at least 4 h at 4◦C.
The following antibodies were used for ChIP: Histone H2B
(39238, Active Motif, RRID:AB 2631110), yH2BK123ub
(this manuscript). Subsequently, 400 l of soluble chro-
matin was added to 40 l prepared Dynabeads and incu-
bated rotating overnight at 4◦C and 1 ml of FA buffer was
added and samples were incubated rotating for 5 min at
room temperature. The beads were washed twice with each
of the buffers FA, FA-HS (50 mM HEPES–KOH, pH 7.5;
500 mM NaCl; 1 mM EDTA; 1% Triton X-100; 0.1% Na-
deoxycholate) and RIPA (10 mMTris, pH 8; 250 mMLiCl;
0.5% NP-40; 0.5% Na-deoxycholate; 1 mM EDTA). Fi-
nally, the beads were washed once with TE (10 mM Tris,
pH 8; 1 mMEDTA). Then 100 l of elution buffer (50 mM
Tris, pH 8; 10 mM EDTA; 1% SDS) was added to the sam-
ples and incubated for 10 min at 65◦C. Subsequently, the
samples were centrifuged 1 min at 21 × g and 80 l of su-
pernatant was collected. Then, 70 l of TE was added to
samples and crosslinks were reversed in 0.625 mg/ml ProtK
and 3 g/ml RNaseA incubated for 1 h at 50◦C and subse-
quently overnight at 65◦C. For input samples, 40l of chro-
matin solution was combined with 60 l elution buffer and
70 l of TE and treated in the same manner as ChIP sam-
ples to reverse crosslinks. DNA was purified by using the
QIAquick PCRPurificationKit (Qiagen). Alternatively, for
some qPCR samples, DNA was extracted by using Chelex-
100 resin (Bio-Rad) (44,45).
Quantitative PCR
All qPCR analyses were performed considering the gen-
eral MIQE guidelines (46) and using the specific condi-
tions described below and the primers described in Sup-
plementary Table S3. Quantitative real time-PCR (qPCR)
was performed with SensiFAST Sybr No-Rox Mix 2x (Bi-
oline) according to the manufacturer’s manual. IP and in-
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put samples were diluted 100 times before analyzing by
qPCR on a LightCycler 480 II (Roche). Cycling parameters
were as follows: 1 cycle pre-incubation: 2 min 50◦C, 10 min
95◦C; 50 cycles amplification: 15 s 95◦C (4.4◦C/s), 60 s 60◦C
(2.2◦C/s) acquisitionmode: single; 1 cycle melting curve: 15
s 95◦C (4.4◦C/s), 60 s 60◦C (2.2◦C/s) 95◦C (0.11◦C/s) acqui-
sition mode: continuous.
ChIP-sequencing and data analysis
Sampleswere pooled equimolarly and subjected to sequenc-
ing on an Illumina HiSeq2000 machine in a single-read 65
bp run. Reads were mapped to the Saccharomyces cere-
visiae reference genome R64-2-1 with BWA version 0.6.1
and filtered for mapping quality below 37 (47). Each read
was extended to 150 bp. Each sample was normalized
for the sequencing depth by converting to Reads per Ge-
nomic Content (RPGC) with DeepTools (48). This was
done by first calculating the sequencing depth: (total num-
ber of mapped reads * fragment length)/effective genome
size (12.1 × 106 bp). Then, the coverage was multiplied by
the scaling factor: 1/sequencing depth to get RPGC. Data
from the biological duplicates were found to be similar and
the datasets were merged for further analyses. Metagene
plots and heatmaps were generated with custom scripts in
R/Bioconductor (49). Reads were either aligned in a win-
dow of −500 to 1 kb around the TSS or +/− 2 kb from
the center of each gene. Genes that contain a coverage of 0
or an average coverage in the first 500 bp below 0.5 were fil-
tered out (5006 out of 5134 genes remained).Geneswere ob-
tained from yeastgenome.org, and transcription data were
obtained fromMcKnight et al. (2015) (50). The small-scale
Epi-ID experiment was performed as described in (20), us-
ing the same ChIP sample as described in that paper.
RESULTS
Genetic interactions between increased dosage of Dot1 and
loss of SAGA-DUB function
Systematic screens for genetic interactions have been used
to uncover gene functions and functional relationships. To
identify unknown functions of Dot1, we determined the ge-
netic interaction profiles of a set of DOT1 alleles in S. cere-
visiae using SGA analysis of a library containing ∼1400
knockouts and decreased abundance by mRNA pertur-
bation (DAmP) mutants, representing a range of biolog-
ical processes with a bias toward nuclear functions (40).
Since gene deletions and increased gene dosage alleles often
uncover different biological functions (51), we analyzed a
dot1Δ strain (lacking all H3K79methylation), Dot1 overex-
pression under control of the strong TDH3/GADPH pro-
moter (Dot1-OE; showing nearly exclusively H3K79me3 at
virtually all H3molecules) and a catalytically inactiveDot1-
G401Rmutant overexpressed by theTDH3 promoter in the
absence of endogenous WT Dot1 protein (Dot1-G401R-
OE). The DOT1 alleles by themselves had no effect on cell
growth and mating efficiency, and showed minimal effects
on the cellular transcriptome by expression profiling (Sup-
plementary Table S4). For the SGA analysis, we crossed the
DOT1 alleles into the mutant library and determined the
genetic interaction maps of the DOT1 alleles using a series
of previously used query genes (40). This resulted in inter-
action scores (S) where a positive score (S > 0) represents
better growth than the expected double mutant fitness and
a negative score (S < 0) worse than expected (Figure 1A).
Deletion of DOT1 showed very few genetic interactions,
as we observed previously (35). Overexpression of Dot1 re-
sulted in a different interaction profile. Among the strongest
negative interactions of increased Dot1 dosage (S<3) were
deletion of UBP8 and SGF11, encoding two of the three
subunits of the deubiquitination module (DUB) of the
SAGA co-activator complex present in the library used
(Supplementary Table S5; Figure 1B and C). These inter-
actions were found in untreated cells as well as in cells ex-
posed to DNA damaging stress (Supplementary Table S5).
Non-DUB SAGA subunits did not show negative interac-
tions (see Supplementary Table S5), indicating that the phe-
notype was not related to the general integrity of the SAGA
complex but specific to the DUB module.
Therefore, we next focused on the cause of the genetic
relationship between SAGA-DUB and increased Dot1 ex-
pression. We previously showed that some genetic inter-
actions in SGA analysis can be caused by synthetic loss
of silencing and thereby loss of mating-type maintenance
(35). For example, the genetic interaction between dot1Δ
and sir1Δ in SGA screens is caused by loss of mating-type
maintenance and therefore specific for the SGA conditions;
synthetic sickness is not observed in standard growth con-
ditions (35). Synthetic loss of mating type in dot1Δsir1Δ
strains was confirmed in the screen described here and was
also observed when sir1Δ was combined with Dot1-OE
or Dot1-G401R-OE (Supplementary Table S5 and Supple-
mentary Figure S1A). We note that deletion of DOT1 or
overexpression ofWT or inactive Dot1 by itself did not lead
to mating defects based on transcriptome analysis (Supple-
mentary Table S4) and based on the fact that all the query
strains efficiently mated to the mutant collection. In con-
trast to genetic interactions caused by synthetic mating de-
fects, the genetic interaction between Dot1-OE and SAGA-
DUB inactivation could be validated under non-SGA con-
ditions and using conditional expression constructs: over-
expression of Dot1 from an inducible GAL1 promoter on a
high-copy plasmid resulted in reduced colony growth in a
ubp8Δ background when compared to an empty plasmid,
whereas no effect on growth was observed in WT strains
(Figure 1D). Therefore, the genetic interaction observed in
the SGA screen was not caused by mating-type defects and
occurred under two independent conditions of Dot1 over-
expression.
The Dot1–SAGA-DUB genetic interaction is independent of
H3K79 methylation
Anegative genetic interaction can be indicative of two genes
affecting the same process by independent pathways or
mechanisms. Following this logic, we first asked whether
the synthetic sickness could be explained by extremely high
H3K79 methylation levels. The Dot1-OE strain already has
very high levels of H3K79me3, leaving only a small amount
of histone H3 with lower methylation states (34,36,52,53).
The absence of Ubp8, leading to more H2Bub1, could lead
to further loss of the lower methylation states (20). To
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Figure 1. Genetic interactions betweenDot1 overexpression and loss of SAGA-DUB suggest a common function ofDot1 andUbp8. (A) Strains expressing
endogenous Dot1 (WT), no Dot1 (dot1Δ), high levels of Dot1 (PTDH3-DOT1) or high levels of catalytically inactive Dot1 (PTDH3-DOT1-G401R) were
crossed to an array of ∼1400 mutant strains and examined for fitness. (B) Fitness score (S) of mutants most affected by overexpression of Dot1 where S
> 0 represents better growth than expected and S < 0 worse growth than expected. (C) Images of plates as an example of the colony fitness defect of the
ubp8Δ strain. (D) Validation of the negative genetic interactions between ubp8Δ and overexpression of Dot1 from a galactose-inducible GAL1 promoter
on a multicopy (2 ) plasmid (+) or using an empty vector control (-).
test this idea, we examined the genetic interactions of the
PTDH3-DOT1-G401R allele, which leads to overexpression
of a Dot1 protein that cannot bind its co-factor SAM and
can therefore no longer methylate H3K79 (34,36,52,53).
Importantly, in this Dot1-G401R-OE strain, no WT copy
of DOT1 was present. The genetic interaction profiles of
overexpressed WT and Dot1-G401R were very similar and
both showed negative interactions with ubp8Δ and sgf11Δ
(Supplementary Table S5; Figure 1B and C). Therefore,
the synthetic sickness was not caused by extremely high
H3K79me levels. In agreement with this, extremely high
H3K79me2/H3K79me3 levels induced by ectopic expres-
sion of Trypanosoma brucei DOT1A or DOT1B proteins
in yeast did not have any obvious effects on growth rate
either (52). Furthermore, unlike overexpressed WT Dot1,
overexpressed catalytically dead (G401R) or compromised
(G401A) Dot1 did not disrupt silencing of telomeric re-
porter genes (Supplementary Figure S1B and C), confirm-
ing that the synthetic sickness did not involve loss of silenc-
ing.
Dot1 promotes H2B ubiquitination
Having excluded H3K79 hypermethylation as the cause of
the synthetic sickness, we next investigated the possibil-
ity that the shared process that SAGA-DUB and overex-
pressed Dot1 regulate is ubiquitination of histone H2B.
On immunoblots, monoubiquitination of H2B results in a
slower migrating band that can be readily detected using
H2B antibodies. Indeed, immunoblot analysis of histone
H2B showed that increased Dot1 expression led to higher
levels of H2Bub1 (Figure 2A and B). This was not caused
by higherH3K79methylation levels because overexpression
of Dot1-G401R also led to more H2Bub1 (Figure 2C and
Supplementary Figure S2A) and expression of TbDOT1A
or TbDOT1B had no effect (Supplementary Figure S2A).
Importantly, overexpression of Dot1 in a ubp8Δ strain fur-
ther elevated the already high levels of H2Bub1 in this back-
ground (Figure 2A). Even though the combined effect of
Dot1-OE and ubp8Δ was additive rather than synergistic,
these findings support the idea that the synthetic sickness of
overexpressed Dot1 and ubp8Δ was caused by a very high
level of H2Bub1. It also shows that the mechanism through
which Dot1 promotes H2Bub1 does not involve inhibition
of Ubp8. To obtain more support for the idea that Ubp8
and Dot1 affect the same process, we investigated whether
Dot1 and Ubp8 regulate ubiquitination on the same site
of H2B, i.e. H2BK123ub1. Two lines of evidence sug-
gested that Dot1 indeed promotes specific ubiquitination of
H2BK123. First, Dot1-dosage dependent H2B monoubiq-
uitination was abrogated by an H2BK123R mutant that
cannot be ubiquitinated on H2BK123 (Figure 2C). Sec-
ond, the effect of Dot1 overexpression on H2Bub1 required
the H2BK123-ubiquitin ligase Bre1 (Figure 2D). However,
Dot1 overexpression did not affect Bre1 protein levels (Fig-
ure 2E) and it did not affect the mRNA expression of Bre1
or other factors known to control H2BK123ub1 levels in
the cell (genes marked in Supplementary Table S4). Ubp8
mRNA and protein levels were also unaltered (Supplemen-
tary Table S4 and Supplementary Figure S2B). ADot1-OE-
induced increase in H2Bub1 was still observed in a paf1Δ
background, in which basal H2BK123ub1 levels are lower
than in WT cells, suggesting that Dot1 acts downstream of
Paf1C to stimulate the activity of Bre1 (Supplementary Fig-
ure S2C; ***P < 0.001).
To directly demonstrate the site of ubiquitination, we
raised a site-specific monoclonal antibody against yeast
H2BK123ub1 using a synthetic Ub-polypeptide antigen
based on amino acids 115–130 of yeast H2B. This anti-
body detects H2BK123ub1 but does not react with un-
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Figure 2. Overexpression of Dot1 promotes H2BK123ub1 independent of deubiquitinases Ubp8 and Ubp10. (A) Immunoblot analysis showing
monoubiquitination of H2B in WT, ubp8Δ and ubp10Δ strains with or without overexpression of Dot1 using an inducible GAL1 promoter on a mul-
ticopy (2 ) plasmid. H2Bub1 can be detected by the slower migrating band using H2B antibodies. The asterisk indicates a non-specific band, shown as a
loading control. The Dot1 antibody was used to show the Dot1 overexpression. (B) Quantification of the immunoblot shown in (A) (H2Bub1/H2B relative
to WT) and biological replicates thereof (N = 3 +/- SD). Statistical significance as determined by an unpaired t-test is indicated by the asterisks (*P <
0.1, **P < 0.05). (C) Immunoblot analysis of strains harboring either WT H2B or H2B-K123R, with either overexpressed Dot1 or Dot1-G401R using
an inducible GAL1 promoter on a multicopy (2 ) plasmid. A site-specific antibody demonstrates that the site of ubiquitination is H2B-K123. Pgk1 was
used as a loading control. (D) Immunoblot analysis of WT and bre1Δ cells with or without overexpression of Dot1 using an inducible GAL1 promoter
on a multicopy (2 ) plasmid. (E) Dot1 overexpression does not affect the expression level of Bre1, the main factor responsible for H2BK123ub1. An
N-terminal FLAG tag was used to preserve the E3 activity. (F) Immunoblot analysis of strains expressing increasing amounts of Dot1 shows that Dot1
promotes H2BK123ub1 in a dose-dependent manner. (G) Quantification of the immunoblot shown in (F) (mean and individual data points of two biolog-
ical replicates). (H) Suppression of synthetic sickness of Dot1-OE and ubp8Δ by an H2BK123Rmutation. Dot1 was overexpressed in the strains indicated
from a galactose-inducible GAL1 promoter on a multicopy (2 ) plasmid (PGAL1-DOT1) and an empty vector was used as a negative control (PGAL1).
Strains were spotted in a 10-fold dilution series and were pre-grown for 24 h in the carbon source indicated.
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modified H2B, free ubiquitin, or ubiquitin covalently at-
tached to H2A (Supplementary Figure S2D). Immunoblot
analysis of bulk histones showed that overexpression of
Dot1 or Dot1-G401R led to increased H2BK123ub1 (Fig-
ure 2C). Finally, the effect ofDot1 onH2BK123ub1was not
just observed at very high levels of overexpression. Anal-
ysis of a series of DOT1 alleles ranging from WT to very
high expression showed a dose-dependent enhancement of
H2BK123ub1 by Dot1 (Figure 2F and G). On the other
hand, deletion ofDOT1 did not lead to lowerH2BK123ub1
levels (Supplementary Figure S2E), suggesting that in WT
cells, the stimulatory effect of Dot1 on H2BK123ub1 is re-
dundant with other mechanisms. Together, these findings
demonstrate that increased Dot1 dosage leads to increased
H2BK123ub1 in a dose-dependent manner, suggesting that
the known crosstalk fromH2Bub1 toH3K79me is also sub-
ject to a reverse crosstalk from Dot1 to H2Bub1.
Finally, having established that Dot1 overexpression
leads to an increased level of H2B ubiquitination and that
this level is even higher in the absence of Ubp8, we tested
whether this very high level of H2Bub1 is responsible for the
genetic interaction of the Dot1-OE ubp8Δ double mutant.
Indeed, introduction of an H2BK123R mutation, which
eliminates all H2BK123ub1, suppressed the synthetic sick-
ness while Dot1 protein overexpression levels in the Dot1-
OE ubp8Δ strain were not affected by the H2BK123R mu-
tation (Figure 2H and Supplementary Figure S2F).
Dot1 overexpression promotes H2BK123ub1 across the
genome
Our results show that Dot1 can promote monoubiquiti-
nation of H2BK123 by Bre1. To obtain more insight into
the role of Dot1 in promoting H2B ubiquitination, we in-
vestigated the changes in H2BK123ub1 upon Dot1 over-
expression by ChIP. ChIP-qPCR with the H2BK123ub1
antibody confirmed that the H2BK123ub1 levels were in-
creased in a ubp8Δ strain, and indicated that overexpres-
sion of a catalytic mutant of Dot1 (Dot1-G401A) led to an
H2BK123ub1 increase in intergenic and transcribed regions
as well (Figure 3A).Multiplexed ChIP, using our previously
developed ChIP-Barcode-Seq Epi-ID technology (20), con-
firmed the increase in H2BK123ub1 at a barcoded reporter
gene in a ubp8Δ strain as well as the strain overexpressing
Dot1 (Supplementary Figure S3A).
We next performed ChIP-sequencing to analyze the pat-
tern of H2BK123ub1 in Dot1 overexpression strains and
how it compared to WT and ubp8Δ strains. No major
changes in H2B occupancy were observed in the mutant
strains (Supplementary Figure S3B). Figure 3B shows the
average H2BK123ub1 pattern across genes at different
expression levels. As expected, in WT cells, the average
H2BK123ub1 levels correlated with gene expression and
peaked across transcribed regions. In the Dot1-OE strain,
the increase in H2BK123ub1 levels that can be observed
on immunoblots (Figure 2) did not affect the general dis-
tribution of H2BK123ub1 (Figure 3B and C). The increase
in H2BK123ub1 occurred across transcribed regions, fol-
lowing the pattern of endogenous H2BK123ub1 as well
as that of H3K79me2/3 laid down by Dot1 (54). Inspec-
tion of different gene expression groups showed that in the
Dot1-OE strain, the difference between highly (group 1)
and lowly (group 5) expressed genes was reduced, indicat-
ing that lowly transcribed genes with low H2BK123ub1 in
WT cells gained relatively more H2BK123ub1 than highly
transcribed genes already marked with higher levels of
H2BK123ub1 in WT cells. These observations together
show that Dot1-OE generally enhances the WT H2BK123
ubiquitination activity, i.e. at transcribed regions where it
normally engages in H3K79 methylation, and especially
affects lowly transcribed genes that harbor low endoge-
nous levels of H3BK123ub1. In contrast, the ubp8Δ strain
showed enrichment of H2BK123ub1 at the 5′ end of genes
(Figure 3B and C) consistent with previous observations
(12), and did not affect lowly transcribed genes more than
highly transcribed genes. The observed activity of Ubp8 at
the beginning of genes is in agreement with the targeting of
the SAGA-DUB complex to promoter regions (12,14). To-
gether, the ChIP-seq results show that Dot1-OE and loss of
Ubp8 stimulate H2BK123ub1 at different locations in the
genome, further strengthening the idea that they stimulate
H2BK123ub1 by distinct mechanisms.
The N-terminus of Dot1 promotes ubiquitination of
H2BK123
Finally, we analyzed a series of Dot1 mutants to obtain
more information on the domains of Dot1 responsible for
the crosstalk. Yeast Dot1 contains an N-terminal part in-
volved in nucleosome binding and the chaperone function
of Dot1, and a C-terminal part harboring the methyltrans-
ferase domain (Figure 4A) (29,55,56). Deletion of the N-
terminal domain (1–172) abolished the effect of Dot1 on
H2BK123ub1 while the remaining C-terminal part of the
protein was still expressed at high levels in this mutant (Fig-
ure 4B). Furthermore, the N-terminus alone, lacking the
methyltransferase domain, could still promote H2B ubiqui-
tination (Figure 4C and D). Therefore, the N-terminal do-
main of Dot1 was necessary and sufficient for the reverse
crosstalk from Dot1 to H2BK123ub1.
DISCUSSION
The H3K79 methyltransferase activity of Dot1 in yeast
and other organisms is regulated by the attachment of a
ubiquitin moiety to the C-terminus of H2B. Here we show
that Dot1 in yeast can in turn promote ubiquitination of
H2B. This suggests that there is a mutual crosstalk be-
tween Dot1 and H2Bub1 that can fine-tune the levels of
H2Bub1 and H3K79me in transcribed regions where the
ubiquitination machinery and Dot1 primarily act. The mu-
tual crosstalk in principle provides a possibility for a pos-
itive feedback loop in which H2Bub1 can promote Dot1
activity and thereby further stimulates H2Bub1. However,
this may not be a general scenario because current evidence
suggests that H2Bub1 promotes the Dot1 catalytic activity
but not the binding to nucleosomes (19,27). At sites where
Dot1 is bound or recruited, however, Dot1 may promote
its own activity by enhancing H2Bub1 synthesis, which will
enhance subsequent H3K79 methylation events by the dis-
tributive Dot1 enzyme (36).
The higher H2Bub1 levels caused by increased Dot1
dosage provide several insights into the functions of Dot1
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Figure 3. Effects of Dot1 overexpression and loss of Ubp8 on H2BK123ub1 in chromatin. (A) ChIP-qPCR analysis of H2BK123ub1 relative to H2B in
transcribed regions in bre1Δ, WT, ubp8Δ and Dot1-G401A overexpression under the control of the strong TDH3 promoter (mean and individual data
points of two biological replicates). (B) Metagene plots of H2BK123ub1 ChIP-seq in WT, ubp8Δ and Dot1-G401A showing the average H2BK123ub1
pattern around the transcription start site. Colored lines represent five different groups based on gene expression level, from high (group 1) to low (group 5)
expression. (C) Heatmaps of read-depth normalized H2BK123ub1 ChIP-seq counts showing the H2BK123ub1 signal in the five different gene expression
groups indicated in B. Genes within each subgroup were ranked on gene length and centered on the gene midpoint.
and H2Bub1. First, we previously showed that forced re-
cruitment of catalytically inactive Dot1 to domains of
silent chromatin in yeast leads to desilencing and sub-
nuclear relocalization (53). The crosstalk from Dot1 to
H2Bub1 that we describe here suggests that these chro-
matin rearrangements induced by Dot1 might be medi-
ated by increased H2Bub1, which in turn can affect chro-
matin structure and downstream histone modifications.
Thus, methyltransferase-independent functions of Dot1 af-
fect biochemical features of chromatin and may also af-
fect the functional output. Second, mutants that affect
H2Bub1 levels generally have profound effects. Mutants of
the SAGA-DUB complex, the Bre1/Rad6/Lge1 ubiquiti-
nation machinery or the upstream regulatory PAF1 com-
plex, andmutants ofH2BK123 all show problemswith gene
expression as well as various fitness defects (11,18,21,42).
Dot1 dosage provides an independent means of manipu-
lating H2Bub1 levels. It surprisingly reveals that increas-
ing overall H2Bub1 levels by Dot1 to a similar extent as
in a ubp8Δ strain affects the expression of only very few
genes (see Supplementary Table S4) and shows no obvious
fitness defects, even when combined with other mutations
(Supplementary Table S5), except for synthetic silencing de-
fects (Supplementary Table S5 and Supplementary Figure
S1A). Thus, even though H2Bub1 in chromatin correlates
well with transcription level, the absolute level of H2Bub1
does not seem to be a strict determinant of gene expression.
Since the distribution of H2Bub1 across genes is not much
altered upon Dot1 overexpression but is altered in ubp8Δ
(Figure 4), it is possible that the relative amount of H2Bub1
across genes is a factor that influences transcriptional out-
put.
How does Dot1 affect H2Bub1? Our results show that
the N-terminus of Dot1 is necessary and sufficient to pro-
mote H2Bub1. This part of Dot1 has been shown to bind to
nucleosomes in vitro and to support full activity of Dot1 in
vitro and in vivo. Moreover, the N-terminus of Dot1 can act
as a derepressor and desilencer when targeted to yeast hete-
rochromatin (53) and was recently shown to be required for
a methyltransferase-independent histone chaperone func-
tion of Dot1 (29). Therefore, it is likely that the stimulatory
effect of Dot1 on H2Bub1 involves interactions with his-
tones or the nucleosome or acts via histone dynamics dur-
ing transcription to subsequently affect enzymes that act
on H2BK123. Cellular H2Bub1 levels reflect the balance
of ubiquitin ligase and deubiquitinase activities. The ge-
netic interactions between Dot1 overexpression and ubp8Δ
(Figures 1 and 2) suggest that Ubp8 and Dot1 make inde-
pendent contributions. Ubp10 is a second deubiquitinase
that removes H2Bub1, but Dot1 can increase H2Bub1 in-
dependent of Ubp8 as well as Ubp10 (Figure 1). There-
fore, it is not likely that Dot1 increases H2Bub1 by interfer-
ing with the activity of Ubp8 or Ubp10. Our results show
that the ubiquitin ligase Bre1 is required for the increase
in H2BK123ub1 by Dot1 overexpression, and that Dot1
acts downstream of Paf1 and hence downstream of tran-
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Figure 4. The N-terminus of Dot1 is necessary and sufficient to promote H2Bub1. (A) Schematic representation of the yeast Dot1 protein and different
mutants used in this study. (B) Deletion of theDot1N-terminal part (DOT1-N-1) abolished the effect of Dot1 onH2Bub1 without altering the expression
level of constitutively overexpressed Dot1. (C) Inducible overexpression in galactose media of the N-terminus alone (Dot1-C) was sufficient to promote
H2Bub1. The lane with DOT1-C-terminal originates from the same blot. The pan-Dot1 antibody was raised against full-length Dot1, but preferentially
recognizes the N-terminus (Supplementary Figure S4). (D) Quantification of the immunoblot shown in (C) (mean and individual data points of two
biological replicates). (E) A model for the mutual crosstalk between Dot1 and H2Bub. The catalysis of (de)modifying reactions is indicated by a black
arrow or bar-headed line. Stimulation is visualized by white arrows. In short, H2BK123ub1 promotes H3K79 methylation by Dot1 and the N-terminus of
Dot1 promotes ubiquitination of H2BK123. The latter stimulation is independent of deubiquitination by Upb8 and the recruitment of Bre1/Rad6 by the
Paf complex, and is thus likely to directly act on ubiquitination by Bre1.
scription elongation. Therefore, we favor the hypothesis that
Dot1 enhances H2BK123ub1 by promoting the synthesis
of H2BK123ub1 by Bre1 (Figure 4E). Recent elegant stud-
ies from the Ko¨hler lab showed that Bre1 interacts with the
acidic patch on the surface of the nucleosome and has mul-
tiple interactions with the ubiquitin-conjugating enzyme
Rad6 to position it on the nucleosome in order to align with
K123 and promote the transfer of ubiquitin (57,58). Inter-
estingly, SAGA-DUB also binds to the nucleosome acidic
patch and competes with Bre1 for binding to the nucleo-
some (57–59). However, mutations of the acidic patch do
not affect Bre1 and SAGA-DUB equally (57), suggesting
that the acidic patch provides opportunities for regulating
competing activities and shifting the balance between ubiq-
uitin synthesis and removal. It is tempting to speculate that
Dot1 might be one such factor that specifically promotes
H2BK123ub1 synthesis, but this idea requires further study.
Finally, the histone H3K4 methyltransferase activities of
MLL3/MLL4 and Set1a have recently been shown to be
dispensable for facilitating enhancer activity and embry-
onic stem cell (ESC) self-renewal, respectively (60,61). In
addition, methyltransferase-independent functions have re-
cently been uncovered for the histone H3K9 methyltrans-
ferase G9a, the H4K20 methyltransferase PR-Set7 and the
H3K4 methyltransferase SETD1A (62–64). Our finding
that Dot1 can promote H2B ubiquitination independent
of H3K79 methylation adds to the growing body of evi-
dence that histonemethyltransferases can harbor important
catalytic activity-independent regulatory functions in chro-
matin.
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